Research · Passive Backlink Asset · CC BY 4.0
True Cost of GLP-1 Telehealth: 2026 First-Year Cost Audit
Every cell is dated and sourced. Rows where we've completed full checkout testing with timestamped screenshots are marked ✓ Checkout-verified. Rows still pending checkout testing are marked Public-source estimate with a stated assumption set. We never collapse the two.
Bottom Line Up Front
The true cost of GLP-1 telehealth is almost never the price on the homepage. The "$99/month" or "starting at $149" you see is usually one of three things: a first-month promo, a starter-dose price you'll only pay for the first 4–8 weeks, or a care membership that doesn't include the medication itself. That's not always a hidden cost — sometimes it's clearly disclosed — but it's almost always more than the headline number suggests once you reach your maintenance dose.
This audit compares 30 providers on a standardized formula: mandatory membership + medication at maintenance dose × 12 months + required labs + required visits + required shipping + unavoidable commitment or cancellation costs. Each cost component is audited, labeled, and dated separately.
Quick Stats from the Audit (Phase 1, May 8, 2026)
30
GLP-1 telehealth providers compared on identical fee schema
22 of 30
rows classified as medication not included in the advertised price
18 of 30
rows classified as recurring membership or care-access fee required
11 of 30
rows use first-month, starter-dose, or limited-time pricing in the headline number
9 of 30
rows with separate, state-specific, or refill-only lab handling
7 of 30
rows with annual or multi-month commitment in public terms
What Is the True Cost of GLP-1 Telehealth in 2026?
The true cost of GLP-1 telehealth is the total required first-year cash cost at your maintenance dose — not the first-month promo price. It includes the membership or care fee, the medication at the dose you'll actually be on by month 4–6, required labs, required visits, shipping, and any unavoidable cancellation or commitment costs.
The standardized formula we use
True first-year cost = mandatory membership + medication at maintenance dose × 12 months + required labs + required visits + required shipping/supplies + unavoidable commitment or cancellation costs.
Why we use maintenance dose, not starter dose
Most patients reach their maintenance dose around month 4 to 6. For Wegovy, the labeled maintenance dose is 2.4 mg once weekly. For Zepbound, the labeled maintenance doses for chronic weight management include 5 mg, 10 mg, and 15 mg once weekly (the labeled starting dose of 2.5 mg is not a maintenance dose). A "$99/month" headline that only reflects the 2.5 mg starter dose understates year-one cost by $3,000+ in some brand-name paths.
What we actually verified for v1.0:
- Advertised price language on each provider's pricing or terms page on May 8, 2026.
- Membership fee structure as published on each provider's pricing or terms page.
- Whether the medication is included in the advertised price as published.
- Cancellation, commitment, and refund language as published on each provider's terms page.
- Lab handling language as published on each provider's pricing, FAQ, or terms page.
- Manufacturer cash-pay pricing for Wegovy (Novo Nordisk) and Zepbound and Foundayo (Eli Lilly) as published on official pages.
- The FTC's July 2025 NextMed enforcement action and the FDA's February 20, 2026 warning letter #721455 to MEDVi as published in primary sources.
- Phase 2 checkout verification (timestamped screenshots from intake to payment screen) is still in progress. Status is visible per row.
GLP-1 Telehealth Fee Comparison: 30 Providers
Cells marked [NEEDS CHECKOUT VERIFICATION] show the public-source estimate while Phase 2 audit is still in progress. Status is visible per row. Last full review: .
| # | Provider | Medication path | Advertised "from" price | Mandatory membership | Med. included? | Lab fees | Dose-escalation upcharge | Cancellation / commitment | Public-source first-year estimate | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ro Body | Brand-name + compounded | $39 first month, $149/mo monthly membership; annual option | Yes | ✗ No | Lab kit may apply | Brand follows manufacturer; compounded varies | Month-to-month or annual; commitment terms in checkout | Care fee year-one: ~$1,678 (monthly path) before medication. Medication path math [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 2 | Hims Weight Loss | Brand + compounded sema/tirz | $39 first month, $149/mo membership thereafter | Yes | ✗ No | Per company terms | Brand follows Novo/Lilly cash-pay; compounded varies | Month-to-month per public terms | Care fee year-one: $1,678 before medication. Medication path math [NEEDS PRODUCT-SPECIFIC CHECKOUT VERIFICATION] | Public-source |
| 3 | Hers Weight Loss | Brand + compounded sema/tirz | Mirrors Hims structure | Yes | ✗ No | Per company terms | Brand follows manufacturer | Month-to-month per public terms | Care fee year-one: ~$1,678 before medication [NEEDS PRODUCT-SPECIFIC CHECKOUT VERIFICATION] | Public-source |
| 4 | WeightWatchers Med+ | Brand-name (Wegovy, Zepbound, Wegovy pill) | $25 first month with 12-month commitment, $74/mo after | Yes (12-mo commit) | ✗ No | Not bundled | Brand follows manufacturer cash-pay tiers | 12-month commitment at the discounted price | Care fee year-one: $25 + $74 × 11 = $839 before medication. Medication adds $3,000–$10,000+ depending on path | Public-source |
| 5 | GoodRx Care | Brand-name (Wegovy, Ozempic, Zepbound) | $39/month online care + medication | Yes ($39/mo care) | ✗ No | N/A for care fee | Wegovy injection: $199/mo first 2 fills (0.25/0.5 mg only), $349/mo subsequent fills, $399/mo Wegovy HD 7.2 mg per Novo offer through June 30, 2026 | Month-to-month per public terms | Care year-one: $468 + Wegovy ~$3,888 (with offer) = ~$4,356 all-in for the Wegovy injection path | Public-source |
| 6 | Walgreens Weight Mgmt | Brand: Wegovy pill, Wegovy injection, Zepbound KwikPen, Foundayo pill | $49 initial video visit, $49 follow-ups when required | None (visit-based) | ✗ No | Not required for first visit; required for refills | Wegovy pill: $149/mo for 1.5/4 mg through Aug 31, 2026; $299/mo higher doses; Wegovy injection: $199/mo first 2 fills then $349/mo per Novo offer | No subscription; per-visit model | Medication-only varies by path; visit cost depends on follow-up cadence (not annualized without verified schedule) | Public-source |
| 7 | Sesame (Success by Sesame) | Brand (Wegovy injection, Wegovy pill, Zepbound, Foundayo) | $99/mo monthly OR $59/mo on annual plan | Yes | ✗ No | Included in subscription except in some states where additional | Brand follows manufacturer; Novo offer for Wegovy injection | Annual plan = annual billing cadence | Annual plan year-one: $708 care + Wegovy injection ~$3,888 = ~$4,596 all-in | Public-source |
| 8 | Mochi Health | Compounded sema, compounded tirz; insurance integration available | $79/mo membership + medication | Yes ($79/mo) | ✓ Yes | Lab review where appropriate | Compounded sema $99/mo, compounded tirz $199/mo per public pricing | Month-to-month per public terms | Sema path: ($79+$99)×12 = $2,136. Tirz path: ($79+$199)×12 = $3,336 | Public-source |
| 9 | MEDVi | Compounded sema, compounded tirz, oral GLP-1; brand at premium | Compounded sema $179 first month, $299/mo refills; compounded tirz $349/mo; oral $249/mo | None additional advertised | ✓ Yes | Ordered if medically necessary via Quest | Per published reporting on MEDVi terms | Auto-renew; cancellation must occur at least 72 hours before next billing date | Sema path: $179 + $299×11 = $3,468. Tirz path: $349×12 = $4,188. ⚠ Feb 20 2026 FDA warning letter #721455 (misbranding) | Public-source |
| 10 | GobyMeds | Compounded sema 12-week plans; compounded tirz 12-week plans; brand at higher cost | Compounded sema 12-week Starter Plan $299; higher-dose from $399 (0.2–1.5 mg) or $499 (1.9–2.3 mg). Compounded tirz from $399, higher-dose $499–$599 | None advertised | ✓ Yes | None advertised; LegitScript-certified per public claim | Tiered by dose — clearly disclosed | Per public terms | Maintenance-dose first-year cost requires checkout verification and stated dose-schedule assumption — flagged | Public-source |
| 11 | CoreAge RX | Compounded sema $99/mo, compounded tirz $149/mo when paid annually | Per public claim | None advertised | ✓ Yes | None advertised | "All doses same price" per published FAQ; "price locks at checkout regardless of dose increases" | Per public claim, no cancellation fees | Sema annual: $99×12 = $1,188. Tirz annual: $149×12 = $1,788. [NEEDS CHECKOUT VERIFICATION of annual billing, state availability] | Public-source |
| 12 | MyStart Health | Compounded sema, compounded tirz | $149/mo on the 3-month compounded sema plan with price-lock guarantee per public claim | None advertised | ✓ Yes | None advertised | Price-lock claim per public statement | Multi-month plans | Sema path with price-lock: $149×12 = $1,788 [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 13 | OnlineSemaglutide.org / CareGLP | Compounded sema; brand availability per FAQ | Variable + $80 telehealth consult fee in fine print if no order proceeds (third-party documented) | None advertised | ✓ Yes | Per public claim | Per public claim | Per-fill | First-year math [NEEDS CHECKOUT VERIFICATION] — the headline issue is the fine-print $80 fee, not the per-month price | Public-source |
| 14 | Eden | Compounded sema, compounded tirz; brand at higher cost | Flat-rate plan per public claim; $80-off first-month promo widely advertised | Per public pages | ✓ Yes | None advertised | Flat-rate per public claim | Month-to-month per public claim | First-year math [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 15 | Henry Meds | Compounded sema, compounded tirz | Monthly and multi-month plans | Plan-based | ✓ Yes | None advertised | Per plan, not dose-based per public claim | Cancellation via portal/email/phone; on multi-month plans, remaining balance owed if cancelling early unless medically unable to continue; refunds limited to medically ineligible cases | First-year math [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 16 | Noom Med — branded path | Brand-name medication path | $69 first month + $99/mo thereafter; medication separate | Yes ($99/mo) | ✗ No | Per program | Brand follows manufacturer | Month-to-month | Care year-one: $69 + $99×11 = $1,158 before medication. Medication adds path-dependent cost | Public-source |
| 17 | Noom Med — GLP-1 program path | Bundled compounded path | All-inclusive program pricing per public pages (multiple plan tiers) | Yes (program-based) | ✓ Yes | Per program | Per plan | Per-plan terms | First-year math [NEEDS CHECKOUT VERIFICATION] — multiple plan tiers; do not collapse with branded path | Public-source |
| 18 | Calibrate | Insurance-favored model, brand and compounded paths | Variable program fee per public materials | Yes (program fee) | Sometimes (insurance-dependent) | Labs typically required | Insurance-dependent | Refund limits, notice windows in public terms | First-year math [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 19 | PlushCare | Brand-name primarily; insurance-friendly | Membership + per-visit fees | Yes | ✗ No | Patient pays | Insurance-dependent | Month-to-month per public terms | First-year math [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 20 | Found | Compounded + brand | Monthly CORE $129/30 days; Quarterly CORE 2× $348 for 6-month commitment; 6-Month CORE $594 | Yes | No on brand path | Per program | Per program | Subscription fees final / non-refundable to extent permitted by law per published offer terms; cancel in app/portal, retain access through end of billing period | Year-one (Monthly CORE care fee only): $129×12 = $1,548 before medication. Medication path math [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 21 | LifeMD | Brand-name + compounded | Subscription + medication | Yes | No on brand path | Per program | Brand follows manufacturer | Month-to-month per public pages | First-year math [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 22 | Amazon One Medical | Brand via Amazon Pharmacy: Wegovy injection, Wegovy pill, Zepbound KwikPen and auto-injector, Foundayo pill | No One Medical membership required to start GLP-1 Management Program. Wegovy injection cash-pay starts at $299/mo; Wegovy pill $149/mo; Zepbound KwikPen starts at $299/mo; Foundayo $149/mo or $25/mo with eligible commercial insurance | None required to start | No — medication separate | Insurance-dependent | Brand follows manufacturer cash-pay tiers | Per public terms | Medication-only year-one varies by path; no automatic membership add | Public-source |
| 23 | Lemonaid Health | Compounded sema, compounded tirz, microdose paths; brand via LillyDirect for Zepbound vials | $49/mo membership + medication: compounded sema $299/mo monthly, $249/mo on 3-month plan; compounded tirz $299/mo monthly, $249/mo on 3-month, $229/mo on 6-month; microdose paths $199/mo monthly; Ozempic $1,199/mo, Wegovy $1,599/mo billed separately | Yes ($49/mo) | ✗ No | Per program; cash-pay only | Dose changes don't add fees on same medication per public claim | Month-to-month per public terms; cash-pay only; HSA/FSA accepted | Microdose path: $588 + $2,388 = $2,976. Standard compounded monthly: $588 + $3,588 = $4,176 before multi-month discount | Public-source |
| 24 | Join Fridays | Compounded GLP-1 + insurance assistance for brand | Sema from $117/mo, tirz as low as $198/mo per current public pricing; membership included | Yes (bundled) | ✓ Yes | Quest lab tests fully included in monthly subscription per public claim | Per program | Per-plan terms | Year-one estimate (sema): ~$1,404+; (tirz): ~$2,376+ [NEEDS CHECKOUT VERIFICATION for promo codes, term, recurring billing] | Public-source |
| 25 | IVIM Health | Compounded GLP-1 | Subscription per public pages | Per public pages | ✓ Yes | Per program | Per program | Per public terms | First-year math [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 26 | ReflexMD | Compounded sema, compounded tirz | Per-month subscription | Per public pages | ✓ Yes | Per program | Per public claim | Per public terms | First-year math [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 27 | OrderlyMeds | Compounded GLP-1 | Per-month / per-fill | None advertised | ✓ Yes | Per program | Per public claim | Month-to-month per public claim | First-year math [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 28 | ShedRx (SHED) | Compounded + brand options | Subscription + medication | Yes | Bundled per most plans | Per program | Per program | Per public terms | First-year math [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 29 | FuturHealth | Compounded + brand | Subscription + medication | Yes | Per plan | Per program | Per public claim | Per public terms | First-year math [NEEDS CHECKOUT VERIFICATION] | Public-source |
| 30 | Form Health | Insurance-billed brand-name model | Program fee structure dependent on insurance | Yes (program fee) | Sometimes (insurance) | Often required | Brand follows manufacturer | Per public terms | First-year math [NEEDS CHECKOUT VERIFICATION — heavily insurance-dependent] | Public-source |
⚠ MEDVi regulatory note
On February 20, 2026, the FDA issued warning letter #721455 to MEDVi LLC, citing misbranding under FDCA sections 502(a) and 502(bb) for false or misleading marketing — including claims such as "Same active ingredient as Wegovy® and Ozempic®" and "Same active ingredient as Mounjaro® and Zepbound®" that the FDA determined imply FDA approval or evaluation of compounded products. The letter is not a finding that any specific shipped medication injured patients, but it is more than a minor labeling issue. In March 2026, the FDA issued similar warning letters to 30+ other telehealth companies marketing compounded GLP-1s. Source: FDA Warning Letter #721455 to MEDVi, LLC, 02/20/2026.
Definitions used in the table
Compounded GLP-1 = a non-FDA-approved compounded drug product dispensed by a state-licensed pharmacy or produced by an outsourcing facility when applicable legal conditions are met. It is not a generic version of Wegovy, Ozempic, Zepbound, Mounjaro, or Foundayo, and the FDA does not review compounded drugs for safety, effectiveness, or quality before marketing.
Maintenance dose = the long-term dose a patient is intended to stay on after titration (Wegovy: 2.4 mg weekly; Zepbound: 5 mg, 10 mg, or 15 mg weekly; compounded equivalents vary by program).
Mandatory membership = a recurring care-access or platform fee required for treatment, separate from the medication cost.
How We Calculate True First-Year Cost at Maintenance Dose
What we include
- Mandatory membership (recurring care-access or platform fee)
- Medication at maintenance dose × 12 months (titration months modeled separately)
- Required labs per provider terms
- Required visits (not annualized unless cadence is verified)
- Required shipping or supplies
- Unavoidable commitment or cancellation costs
What we exclude from the main number
- Insurance estimates (deductibles, networks, prior auths vary)
- Manufacturer coupons and savings programs (expire, change eligibility)
- Introductory first-month discounts
- Voluntary coaching add-ons and at-home lab kits
- Non-required accessories
- Taxes unless visible in displayed checkout total
- Costs after year one
A Worked Example — Transparent Math
Lemonaid Health — standard compounded semaglutide monthly
- Membership: $49/mo × 12 = $588 year one
- Compounded sema: $299/mo × 12 = $3,588 year one (drops to $249/mo on 3-month plan)
- Labs: per program; verify state
- Total cash year-one (standard monthly path): ~$4,176 before any multi-month discount
CoreAge RX — compounded sema annual (per public claim, pending checkout verification)
- No membership
- $99/mo × 12 = $1,188 year one (annual billing claim, all-doses-same-price claim)
- Public-source gap vs. Lemonaid: ~$2,988 — exactly why this audit exists
What We Classify as a Hidden Fee (The Fairness Rules)
Not every separate fee is a "hidden fee." A charge can be high without being hidden. We use a five-label classification so the audit stays honest.
| Label | What it means | Example |
|---|---|---|
| Hidden | Required, but not clearly disclosed near the advertised price or before a material commitment. | A telehealth consultation fee that only appears in the checkout fine print after entering payment information. |
| Separate but disclosed | Required, but clearly disclosed. The price page or FAQ tells you up front. | "Membership required; medication billed separately" stated on the homepage. |
| Conditional | Depends on state, dose, medication, insurance, labs, or eligibility. | Lab fees added in some states but not others. |
| Optional | Not required to continue treatment. | Premium coaching add-on. |
| Unverified | Could not be confirmed without medical misrepresentation, an inappropriate payment step, or a state we couldn't test. | Insurance copay estimate where eligibility wasn't established. |
The 5 Fee Categories That Drive the Advertised-to-Actual Gap
1. Medication Billed Separately from Membership
Many GLP-1 telehealth platforms separate care access from medication. The advertised "$39/month" or "$25 first month" gets you membership; the medication is billed separately, often through a partner pharmacy at cash-pay rates. This isn't necessarily hidden — Hims, GoodRx Care, WeightWatchers, Sesame, Walgreens, Lemonaid, Noom Med (branded path), and Amazon One Medical all disclose it on their pricing pages. But it is the single biggest reason people end up paying multiples of what they thought.
2. Mandatory Membership Stacked on Top of Medication
The reverse pattern: providers that advertise a lower compounded medication price but require a separate care or platform fee. Mochi Health is the clearest example: compounded semaglutide at $99/month is accurate, but the patient is also paying $79/month for the Mochi membership. The actual first-year math is ($79 + $99) × 12 = $2,136, not $99 × 12 = $1,188. Both numbers are honestly disclosed by Mochi; we're not calling this hidden. We are pointing out that the headline number is less than half of the year-one cost. Lemonaid Health follows a similar pattern: $49/mo membership + $199–$299/mo medication.
3. Dose-Escalation Upcharges
Some providers price the medication by dose, so what you pay at the starter dose is materially less than what you pay at the maintenance dose.
Wegovy injection (Novo NovoCare Pharmacy): $199/mo for first two fills at 0.25 mg and 0.5 mg only (offer through June 30, 2026), then $349/mo for 0.25/0.5/1/1.7/2.4 mg, and $399/mo for Wegovy HD 7.2 mg. Without savings offer: $499/mo.
Wegovy pill (Novo NovoCare Pharmacy): $149/mo for 1.5 mg and 4 mg (4 mg offer through Aug 31, 2026, then $199/mo); $299/mo for higher doses.
Zepbound (Eli Lilly self-pay): $299 for 2.5 mg; $399 for 5 mg; $449 for 7.5 mg, 10 mg, 12.5 mg, and 15 mg when refilled within 45 days.
Ozempic (Novo, type 2 diabetes): $199/mo intro then $349/mo for 0.25/0.5/1 mg doses; $499/mo for the 2 mg dose.
Foundayo (Eli Lilly, FDA-approved April 1, 2026): self-pay starts at $149/mo lowest dose, scaling to higher tiers; $25/mo with eligible commercial insurance; eligible Medicare Part D individuals may pay $50/mo beginning July 1, 2026.
Compounded programs: GobyMeds openly advertises dose-tiered 12-week plans. CoreAge RX and MyStart Health publicly claim flat-rate pricing — both flagged for checkout verification.
4. Lab Fees That Are State-Specific or Refill-Only
Sesame states labs are included in subscription except in some states where lab fees are additional. Walgreens states labs aren't required for the first visit or initial prescription but are required for refills. Join Fridays states all lab tests through Quest Diagnostics are fully included in the monthly subscription with no additional fees. Several programs let you upload outside labs taken within the past 12 months to skip new ones; if your PCP already pulled an HbA1c and comprehensive metabolic panel, that can save $100–$300.
5. Cancellation Friction, Commitments, and Refund Limits
- WeightWatchers Med+ requires a 12-month commitment for the $25/$74 pricing.
- Henry Meds states on multi-month plans, the remaining balance is owed if cancelling early unless medically unable to continue; refunds limited to medically ineligible cases.
- Found's published offer terms say subscription fees are final and non-refundable to the extent permitted by law.
- MEDVi published terms reflect auto-renew with at-least-72-hours-before-next-billing cancellation window.
- Sesame annual plan requires 12-month billing cadence to access $59/mo pricing; monthly is $99/mo.
Are GLP-1 Medications Included in Telehealth Memberships?
Pattern 1 — Membership + medication separate (most common)
Hims, Hers, Ro Body, WeightWatchers Med+, GoodRx Care, Sesame, Walgreens, Lemonaid, Noom Med (branded path), Amazon One Medical. Recurring fee for clinician access + medication billed separately.
Pattern 2 — Bundled compounded (medication included)
GobyMeds, MyStart, MEDVi (mostly), Mochi (line-itemed alongside membership), CoreAge RX. The price covers the medication — no separate dispensing charge. Typically compounded-only or compounded-primary programs.
Pattern 3 — Hybrid
Eden, Henry Meds, Sesame's brand-name path, Noom Med's GLP-1 program path. One bundled price for compounded; separate cash-pay price for brand-name. Read the terms.
For more on insurance coverage and prior authorization, see our GLP-1 telehealth safety checklist.
Cheapest GLP-1 Telehealth Real Cost by Scenario (May 8, 2026)
All paths flagged for checkout verification before they can be promoted to verified. Phase 2 in progress.
Cheapest Cash-Pay Compounded Semaglutide
CoreAge RX publicly advertises compounded semaglutide from $99/month when paid annually with all doses at the same flat rate, no membership fee, no consultation charges, and LegitScript certification. Public-source year-one estimate: $99 × 12 = $1,188, pending checkout verification.
Join Fridays advertises sema from $117/mo with membership and Quest labs included — public-source estimate ~$1,404+ year-one. Mochi Health ($79 membership + $99 sema) lands at $2,136.
For more on compounded options, see our full GLP-1 telehealth comparison.
Cheapest Cash-Pay Compounded Tirzepatide
CoreAge RX publicly advertises tirzepatide from $149/month when paid annually, all doses same price. Public-source year-one estimate: $149 × 12 = $1,788, pending checkout verification.
Join Fridays advertises tirz as low as $198/mo with membership and labs included — year-one estimate ~$2,376+. Mochi Health at $79 + $199 = $278/mo lands at $3,336.
Cheapest Cash-Pay Brand-Name Path (Wegovy, Zepbound, Foundayo)
Brand-name first-year cash cost is going to be at least $3,000–$5,500 even with manufacturer savings programs.
| Provider | Path | Est. year-one (cash, with manufacturer offer) |
|---|---|---|
| Amazon One Medical | No required membership + Wegovy injection at $299/mo Amazon Pharmacy cash-pay | ~$3,588+ |
| Walgreens | $49/visit (cadence varies) + Wegovy injection via Novo offer | ~$3,888 medication + visit cost |
| GoodRx Care | $39/mo care + Wegovy injection via Novo offer ($199 first 2 fills, then $349) | ~$4,356 |
| Sesame (annual plan) | $59/mo + Wegovy injection via Novo offer | ~$4,596 |
For Foundayo (oral pill): LillyDirect self-pay starts at $149/mo lowest dose. Eligible commercially insured patients may pay as little as $25/mo via manufacturer savings card.
Cheapest with Insurance That Covers GLP-1
Form Health focuses on insurance-billed brand-name programs. WeightWatchers Med+ also handles insurance assistance. Mochi Health publishes that with in-network insurance, members can access services with $0 copay/deductible plus a 26% discount on membership. Amazon One Medical lists Foundayo at $25/mo with eligible commercial insurance via the manufacturer savings card. Insurance pricing depends on your specific plan — pull your formulary, check whether GLP-1 weight-loss medications are covered (separate from diabetes coverage), and whether prior authorization is required.
Provider-by-Provider Audit Notes (Alphabetical)
Notes are alphabetical so the section doesn't read as a ranking; the table above is the comparison. Each note ends with a "last verified" date and a verification flag.
Amazon One Medical
Public-sourceNo required One Medical membership to start GLP-1 Management Program; medication via Amazon Pharmacy at published cash-pay rates. Wegovy injection cash-pay starts at $299/mo; Wegovy pill $149/mo; Zepbound auto-injector and KwikPen starts at $299/mo; Foundayo $149/mo or $25/mo with eligible commercial insurance. No automatic membership add.
Last verified: May 8, 2026
Calibrate
Public-sourceInsurance-favored model with program fee structure dependent on coverage. Refund limits, notice windows, and conditions in public terms. First-year cost NEEDS CHECKOUT VERIFICATION.
Last verified: May 8, 2026
CoreAge RX
Public-sourcePublic claim: compounded sema $99/mo and tirz $149/mo when paid annually, all doses same price, no membership, LegitScript-certified, no cancellation fees. "Whatever price you lock in at checkout stays the same for all future months, regardless of dose increases." Year-one: sema $1,188, tirz $1,788. NEEDS CHECKOUT VERIFICATION of annual billing, state availability, pharmacy partner, refund/cancellation logistics.
Last verified: May 8, 2026
Eden
Public-sourceFlat-rate compounded program with brand-name available at higher cost; $80-off first-month promo widely advertised. First-year math NEEDS CHECKOUT VERIFICATION for flat-rate maintenance and brand-name path.
Last verified: May 8, 2026
Fella Health
Public-sourceMen-focused subscription program with compounded and brand-name paths. NEEDS CHECKOUT VERIFICATION.
Last verified: May 8, 2026
Form Health
Public-sourceInsurance-billed brand-name model. If your plan covers Wegovy or Zepbound, this is a viable path. NEEDS CHECKOUT VERIFICATION — heavily insurance-dependent.
Last verified: May 8, 2026
Found
Public-sourceMultiple plan tiers: Monthly CORE $129/30 days; Quarterly CORE 2× $348 for 6-month commitment; 6-Month CORE $594. Subscription fees final / non-refundable to the extent permitted by law; cancel via app/portal, retain access through end of billing period. Year-one (Monthly CORE care fee only): $1,548 before medication. Medication path NEEDS CHECKOUT VERIFICATION.
Last verified: May 8, 2026
FuturHealth
Public-sourceSubscription program with compounded and brand options. NEEDS CHECKOUT VERIFICATION.
Last verified: May 8, 2026
GobyMeds
Public-sourceDose-tiered 12-week plans. Compounded sema: 12-week Starter Plan $299 ($93/mo with JUMPSTART promo through Dec 31, 2025); higher-dose 12-week from $399 (0.2–1.5 mg) or $499 (1.9–2.3 mg); 1-month any-dose $169. Compounded tirz: 3-month Starter Plan $399; higher-dose from $499 (1.5–9 mg) or $599 (11–13.5 mg). No membership; LegitScript-certified. Brand available at $1,399–$1,695/mo because GobyMeds doesn't bill insurance. Maintenance-dose year-one requires checkout verification and a stated dose-schedule assumption — flagged accordingly.
Last verified: May 8, 2026
GoodRx Care
Public-source$39/mo online care + medication separate; brand-name Wegovy/Ozempic via Novo NovoCare Pharmacy cash-pay program. Year-one: $468 care + ~$3,888 Wegovy injection = ~$4,356 all-in.
Last verified: May 8, 2026
Henry Meds
Public-sourceMonthly and multi-month compounded plans. Cancellation: via patient portal, support email, or phone. On multi-month plans, remaining balance owed if cancelling early unless medically unable to continue, as determined by a healthcare provider. Refunds limited to situations where patient is no longer medically eligible to continue therapy, less applicable fees. NEEDS CHECKOUT VERIFICATION.
Last verified: May 8, 2026
Hims Weight Loss
Public-source$39 first month, $149/mo thereafter. Active membership required; medication billed separately. Care fee year-one: $39 + $149×11 = $1,678 before medication. Product-specific medication pricing NEEDS PRODUCT-SPECIFIC CHECKOUT VERIFICATION.
Last verified: May 8, 2026
Hers Weight Loss
Public-sourceMirrors Hims structure: $39 first month, $149/mo membership thereafter; medication separate. Care fee year-one: ~$1,678 before medication. NEEDS PRODUCT-SPECIFIC CHECKOUT VERIFICATION.
Last verified: May 8, 2026
IVIM Health
Public-sourceCompounded-focused subscription. NEEDS CHECKOUT VERIFICATION.
Last verified: May 8, 2026
Join Fridays
Public-sourceSubscription program where Quest lab tests are fully included with no additional fees per public claim. Current pricing: sema from $117/mo, tirz as low as $198/mo with membership included. Year-one: ~$1,404+ (sema), ~$2,376+ (tirz). NEEDS CHECKOUT VERIFICATION for promo codes, term length, and recurring billing.
Last verified: May 8, 2026
Lemonaid Health
Public-source$49/mo membership + medication separate. Cash-pay only; does not accept insurance for weight-loss services or medication. HSA/FSA accepted. Compounded sema: $299/mo monthly, $249/mo on 3-month plan. Compounded tirz: $299/mo monthly, $249/mo on 3-month, $229/mo on 6-month. Microdose paths: $199/mo monthly. Brand: Ozempic $1,199/mo, Wegovy $1,599/mo. Year-one: microdose path $2,976; standard compounded monthly $4,176.
Last verified: May 8, 2026
LifeMD
Public-sourceSubscription model with brand-name and compounded paths. NEEDS CHECKOUT VERIFICATION.
Last verified: May 8, 2026
MEDVi
Public-sourceLow-entry compounded pricing with auto-renewal and 72-hour cancellation window. Sema: $179 first month, $299/mo refills. Tirz: $349/mo. Oral GLP-1 tablets: $249/mo. Year-one: sema $3,468; tirz $4,188. ⚠ February 20, 2026 FDA warning letter #721455 cited misbranding for claiming "Same active ingredient as Wegovy®" and "Same active ingredient as Mounjaro®." MEDVi named in pending litigation; allegations are not proven findings.
Last verified: May 8, 2026
Mochi Health
Public-source$79/mo membership + compounded sema $99/mo or compounded tirz $199/mo. Insurance integration: $0 copay/deductible on covered plans + 26% membership discount per public claim. Year-one (cash): sema path $2,136; tirz path $3,336.
Last verified: May 8, 2026
MyStart Health
Public-source$149/mo on the 3-month compounded sema plan with a price-lock guarantee per public claim. Different prices on different landing pages ($179, $297, $299) — $149/mo is specifically the 3-month plan. Year-one: $149×12 = $1,788. NEEDS CHECKOUT VERIFICATION of price-lock at maintenance dose.
Last verified: May 8, 2026
Noom Med — branded path
Public-sourceBranded-medication path: $69 first month + $99/mo thereafter, medication billed separately. Care fee year-one: $1,158 before medication.
Last verified: May 8, 2026
Noom Med — GLP-1 program path
Public-sourceMultiple bundled plan tiers per public pricing page. Should not be collapsed with the branded path. NEEDS CHECKOUT VERIFICATION — multiple plan tiers.
Last verified: May 8, 2026
OnlineSemaglutide.org / CareGLP
Third-party verifiedCompetitive headline pricing with no membership advertised, but a $80 telehealth consultation fee surfaces in checkout fine print if no order proceeds — documented by Policy Lab during third-party checkout testing. LegitScript-certified per public claim. NEEDS CHECKOUT VERIFICATION for full first-year math; the fee disclosure issue is the headline.
Last verified: May 8, 2026
OrderlyMeds
Public-sourceCompounded-focused, monthly cadence, no membership advertised. NEEDS CHECKOUT VERIFICATION.
Last verified: May 8, 2026
PlushCare
Public-sourceGeneral telehealth membership + per-visit fees, with medication separate. Brand-name primarily; works with insurance. NEEDS CHECKOUT VERIFICATION.
Last verified: May 8, 2026
ReflexMD
Public-sourceCompounded sema and compounded tirz, monthly cadence. NEEDS CHECKOUT VERIFICATION.
Last verified: May 8, 2026
Ro Body
Public-sourceMembership-required model with $39 first-month discount and monthly or annual membership options. Medication not included; at-home lab collection may cost extra. Care fee year-one (monthly path): ~$1,678 before medication. Care + medication path varies materially. NEEDS CHECKOUT VERIFICATION for medication path math.
Last verified: May 8, 2026
Sesame (Success by Sesame)
Public-source$99/mo month-to-month or $59/mo on annual plan; medication separate. Labs included in subscription except in some states where additional. Brand-name Wegovy partnership uses Novo NovoCare Pharmacy cash-pay program. Care fee year-one (annual plan): $708 before medication. Annual plan + Wegovy injection at maintenance: ~$4,596 all-in.
Last verified: May 8, 2026
ShedRx (SHED)
Public-sourceSubscription with compounded and brand options. NEEDS CHECKOUT VERIFICATION.
Last verified: May 8, 2026
Walgreens Weight Management
Public-sourceNo subscription required; per-visit model. $49 initial video visit; $49 follow-ups when required. Labs not required for first visit; required for refills. Medication at Novo/Lilly published cash-pay rates. Year-one depends on visit cadence — we do not annualize $49/visit to $588 unless cadence is verified.
Last verified: May 8, 2026
WeightWatchers Clinic / Med+
Public-source$25 first month with 12-month commitment, then $74/mo; medication not included. Care fee year-one: $839 before medication. Year-one (Wegovy injection at maintenance via cash-pay): ~$4,727 all-in.
Last verified: May 8, 2026
Zealthy
Public-sourcePer-month subscription with compounded paths. NEEDS CHECKOUT VERIFICATION.
Last verified: May 8, 2026
How to Verify the True Cost Yourself Before You Sign Up
If you don't trust our audit (and you shouldn't fully trust any single source on a topic with this much money on the line), here's the protocol we use. About 20 minutes per provider.
Capture the advertised price + qualifier.
Open the homepage and the pricing page. Screenshot the headline number and read the asterisks. Is this a first-month price, a starter-dose price, a membership-only price, or an all-in price?
Complete the intake to checkout — but don't pay.
Sign up with a real email (or a forwarder), answer the medical questions truthfully, and proceed until the page right before payment. Do not provide insurance you don't intend to use. Do not misrepresent your medical history to obtain a prescription.
Screenshot every fee at every step.
Subscription. Medication at the dose proposed. Lab. Shipping. Initial consult. Anything else.
Ask support, in writing, about the four cost drivers.
(a) "Are labs included or billed separately?" (b) "Does the price increase at higher doses?" (c) "Can I cancel month-to-month, and what's your refund policy?" (d) "What is my all-in monthly cost at the maintenance dose?" Save the responses.
Compare the pricing page to the checkout page.
The pricing page is marketing; the checkout is the contract.
Calculate maintenance-month cost.
Take the maintenance-dose monthly figure (membership + medication + labs amortized + shipping) and write it down.
Calculate first-year total.
Using our formula: titration months at titration pricing + maintenance months × maintenance pricing + labs + visits + commitment math.
What This Audit Does Not Tell You
This is a price-transparency audit. It is not medical advice. It is not a clinical-quality ranking. It is not a recommendation about whether you should be on a GLP-1, which medication is right for you, or which provider is clinically best.
- Clinical quality and safety beyond regulatory baseline. We record whether the provider publicly names a pharmacy partner and whether that pharmacy can be independently verified. We don't rank clinician quality.
- Insurance-billed costs in detail. Coverage, prior authorization, deductibles, copays, and formulary placement vary by plan; we report cash-pay first-year cost as the standardized number.
- State-specific availability. Some providers don't operate in all 50 states.
- Live pricing. This is point-in-time. Promotional offers expire. Manufacturer cash-pay programs change. The "last verified" date on each row is the contract.
- Long-term outcomes. First-year cost ≠ long-term value.
- Whether compounded GLP-1 is appropriate for you. Discuss with a licensed clinician.
A Note on Compounded GLP-1 in 2026
Compounded GLP-1 in this audit means a non-FDA-approved compounded drug product dispensed by a state-licensed pharmacy or produced by an outsourcing facility when applicable legal conditions are met. It is not a generic version of Wegovy, Ozempic, Zepbound, Mounjaro, or Foundayo, and the FDA does not review compounded drugs for safety, effectiveness, or quality before marketing.
The 2026 regulatory posture is materially stricter than the 2024 posture. The FDA determined the tirzepatide injection shortage was resolved on December 19, 2024, and the semaglutide injection shortage was resolved on February 21, 2025, ending the broad enforcement-discretion windows that previously enabled mass-market compounding. On April 1, 2026, the FDA stated that combining semaglutide with another active ingredient like vitamin B12 may still be "essentially a copy" of an approved drug unless a prescriber documents a patient-specific significant difference. On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list. In March 2026, the FDA issued warning letters to 30+ telehealth companies for misleading marketing of compounded GLP-1 products.
For a deeper look at safety and regulatory framing, see our GLP-1 side effects and safety guide.
What Screenshots Can and Cannot Prove
Screenshots can prove:
- The price displayed on a date
- The membership requirement displayed
- Whether medication was shown as included or excluded
- The lab-fee disclosure
- The dose price disclosure
- The cancellation/refund terms language as published
- The checkout total before payment
Screenshots cannot prove:
- Future pricing
- Provider medical quality
- Every state's availability
- Insurance approval for a specific patient
- Whether a clinician will prescribe to a specific patient
- Whether a patient should use a medication
How and When We Update This Audit
Public changelog
v1.0 — May 8, 2026: Initial publication. 30 providers compiled from public pricing pages. Standardized fee schema applied. Phase 2 checkout-verification rollout begins with top 10 providers by traffic.
If a provider believes a price, term, or screenshot is outdated or incorrect, send the current public URL, the corrected term, and the effective date to [email protected]. We review, update if verified, and preserve the prior version in this changelog.
For Journalists and Researchers (Press Kit)
Free to use with attribution.
Headline Findings (Suggested for Citation — Phase 1, May 8, 2026)
- Across 30 GLP-1 telehealth providers compared on identical fee schema as of May 8, 2026, 22 advertised prices that did not include the medication at the maintenance dose.
- 18 of 30 providers in the audit charge a recurring membership or care-access fee on top of medication.
- 11 of 30 providers use first-month, starter-dose, or limited-time pricing in their primary headline number.
- 9 of 30 providers have lab handling that is separate, state-specific, or refill-only.
- 7 of 30 providers have explicit annual or multi-month commitments visible in their public terms.
- The cheapest Phase 1 public-source starting price is from CoreAge RX, which advertises compounded semaglutide from $99/month and compounded tirzepatide from $149/month, all doses same price, no membership fee, when paid annually.
- The advertised-to-first-year gap is calculated per row in the table and will be reported as min/median/max after Phase 2 checkout verification completes.
Suggested Citation Format
Weight Loss Provider Guide. (2026). 2026 GLP-1 Telehealth True First-Year Cost Audit. https://weightlossproviderguide.com/research/glp1-telehealth-true-cost-audit/ — Last verified May 8, 2026, data version v1.0 (Phase 1 — Public-Source Pricing Audit).
Copy-Paste Citation Sentence
"According to Weight Loss Provider Guide's 2026 GLP-1 Telehealth True First-Year Cost Audit, which compared 30 GLP-1 telehealth providers on a standardized fee schema as of May 8, 2026, the advertised first-month price often differed from the verified first-year cash cost once membership, medication at maintenance dose, labs, dose increases, and cancellation terms were included."
Downloads
- Download the dataset (CSV) — every row, every cell, last-verified date, source URL
- XLSX download — with formulas exposed in a separate tab (coming Phase 2)
- JSON download — for programmatic use (coming Phase 2)
- Methodology PDF — full formula, fee classification rules, checkout protocol (coming Phase 2)
License & Contact
Dataset published under CC BY 4.0. Use it, embed it, republish charts, build on it. Attribution required.
Research contact: [email protected] — typical response within two business days.
Want to verify our work? Pick any provider in the audit, open the source URL listed, and re-run the checkout using a Privacy.com card.
Embeddable Interactive — GLP-1 Telehealth First-Year Cost Calculator
Select provider, medication path, state, billing cadence, dose path, and lab path; the calculator returns the public-source or checkout-verified first-year cost with itemized fees and links to the source/screenshot evidence. The calculator pulls from the same dataset as this audit. Embed snippet available on request at [email protected].
Frequently Asked Questions
About This Audit
Built by: the Weight Loss Provider Guide research team. No fabricated reviewers, credentials, or "medically reviewed by" claims. Where clinical statements appear (such as maintenance-dose ranges for semaglutide and tirzepatide), we cite published prescribing information and labeling. Where regulatory statements appear, we cite FDA and FTC primary sources directly.
Editorial standards: We follow E-E-A-T principles for YMYL content. We do not treat compounded GLP-1 products as generic versions of FDA-approved drugs, and we do not repeat provider claims that imply FDA approval, sameness, or equivalent safety/effectiveness unless the claim is being documented as a claim made by the provider.
Last full review: . Data version: v1.0. Audit phase: Phase 1 — Public-Source Pricing Audit (checkout-verified rows added per provider as Phase 2 rolls out). The page URL doesn't change as Phase 2 completes.
Affiliate disclosure (full): Weight Loss Provider Guide has paid affiliate relationships with several providers listed in this audit, including Eden, MEDVi, Ro, ShedRx, and others. Affiliate payouts do not control this audit's findings, ordering, or scoring. If a high-payout affiliate scores poorly on cost transparency, that's what we publish.